Nicholas Metrus, MD
Neurology · Summit, NJNPI 1356785067
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,100 of the $49,072 with a category attached, or 85.8%. Novocure Inc. accounts for 98.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $28,014 and has fallen 75.2% since, to $6,956 in 2025. Among neurology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $412.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$48K
- Telix Pharmaceuticals$190
- Teva Pharmaceuticals USA, Inc.$140
- UCB, Inc.$138
- Servier Pharmaceuticals LLC$109
- Aucta Pharmaceuticals, Inc.$94
- plus $227 from 10 others
What the payments were for
- Consulting fees$7502%
- Speaking & faculty fees$42,10086%
- Travel & lodging$9442%
- Food & beverage$5,16711%
- Education$1110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 84 | $48,175 |
| Telix Pharmaceuticals | 3 | $190 |
| Teva Pharmaceuticals USA, Inc. | 3 | $140 |
| UCB, Inc. | 2 | $138 |
| Servier Pharmaceuticals LLC | 6 | $109 |
| Aucta Pharmaceuticals, Inc. | 7 | $94 |
| Eisai Inc. | 4 | $63 |
| Johnson & Johnson | 2 | $36 |
| Springworks Therapeutics, Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Caris MPI, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Ipsen Biopharmaceuticals, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune$39,982
- Optune Gio$6,475
- Oncology$418
- ILLUCCIX$278
- Briviact$124
How this compares
$49,072 in reported general payments places this provider in the 90th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 24 | $2,008 |
| Duloxetine Hcl | 20 | $1,122 |
| Levetiracetam | 38 | $698 |
| Dexamethasone | 30 | $431 |
| Amitriptyline Hcl | 16 | $288 |
| Gabapentin | 31 | $263 |
| Ondansetron Hcl | 12 | $85 |
| Propranolol Hcl | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other neurology in Summit
- Marcie RabinSummit$387K
- Seth StollerSummit$35K
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Ashish KapoorBayonne$329K
- Mario VukicHackensack$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.